For research use only. Not for therapeutic Use.
Ecopipam hydrochloride（Cat No.:I026700）is a selective dopamine D1 receptor antagonist being studied for its potential therapeutic applications in treating neuropsychiatric disorders, particularly those involving dopamine dysregulation. It works by blocking the D1 receptor, which plays a key role in regulating mood, cognition, and motor control. Ecopipam has shown promise in clinical trials for conditions such as schizophrenia, attention deficit hyperactivity disorder (ADHD), and anxiety disorders, by modulating dopamine activity. By targeting specific pathways in the brain, Ecopipam may provide an alternative treatment for patients with disorders related to dopamine imbalance.
| CAS Number | 190133-94-9 |
| Synonyms | (6aS,13bR)-11-chloro-7-methyl-5,6,6a,8,9,13b-hexahydronaphtho[1,2-a][3]benzazepin-12-ol;hydrochloride |
| Molecular Formula | C19H21Cl2NO |
| Purity | ≥95% |
| IUPAC Name | (6aS,13bR)-11-chloro-7-methyl-5,6,6a,8,9,13b-hexahydronaphtho[1,2-a][3]benzazepin-12-ol;hydrochloride |
| InChI | InChI=1S/C19H20ClNO.ClH/c1-21-9-8-13-10-16(20)18(22)11-15(13)19-14-5-3-2-4-12(14)6-7-17(19)21;/h2-5,10-11,17,19,22H,6-9H2,1H3;1H/t17-,19+;/m0./s1 |
| InChIKey | APFMVAHRFWBCDG-JUOYHRLASA-N |
| SMILES | CN1CCC2=CC(=C(C=C2[C@@H]3[C@@H]1CCC4=CC=CC=C34)O)Cl.Cl |
| Reference |
|
